Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway

Cancer Res. 2004 Nov 1;64(21):7706-10. doi: 10.1158/0008-5472.CAN-03-3897.

Abstract

Melanoma cells typically express wild-type p53, yet they are notoriously resistant to DNA-damaging agents. Here, we show that sodium butyrate (NaB), a histone deacetylase (HDAC) inhibitor, induced apoptosis in human melanoma cells in a dose- and time-dependent manner. Apoptosis was associated with HDAC1-dependent induction of Bax and acetylation of p53. Down-regulation of HDAC1 by an antisense vector sensitized the cells to NaB-induced apoptosis, whereas its overexpression conferred resistance to this agent. Increased HDAC1 levels and activity impaired NaB-mediated activation of Bax promoter and Bax protein levels. Finally, using p53-null melanoma cell line and RNA interference in cells expressing wild-type p53 protein, we show that Bax induction and NaB-mediated apoptosis is p53 dependent.

MeSH terms

  • Apoptosis / drug effects*
  • Butyric Acid / pharmacology*
  • Cell Line, Tumor
  • Histone Deacetylase 1
  • Histone Deacetylases / physiology*
  • Humans
  • Melanoma / pathology*
  • Promoter Regions, Genetic
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Tumor Suppressor Protein p53 / physiology*
  • bcl-2-Associated X Protein

Substances

  • BAX protein, human
  • Proto-Oncogene Proteins c-bcl-2
  • Tumor Suppressor Protein p53
  • bcl-2-Associated X Protein
  • Butyric Acid
  • HDAC1 protein, human
  • Histone Deacetylase 1
  • Histone Deacetylases